Arzeda and Zymergen Sign Multi-Year Deal to Combine Archytas™/Scylax™ Design Tools with Zymergen’s High-Throughput Strain Platform

Arzeda and Zymergen signed a multi-year agreement to combine Arzeda’s computational enzyme and pathway design tools (Archytas™ and Scylax™) with Zymergen’s high-throughput strain construction platform to design, build, and test strains for producing novel molecules and materials.